Published in J Med Chem on May 07, 2013
Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis. Chem Rev (2014) 1.00
Immunomodulatory and Antileishmanial Activity of Phenylpropanoid Dimers Isolated from Nectandra leucantha. J Nat Prod (2015) 0.82
Terpenes increase the lipid dynamics in the Leishmania plasma membrane at concentrations similar to their IC50 values. PLoS One (2014) 0.80
Investigational drugs for visceral leishmaniasis. Expert Opin Investig Drugs (2014) 0.79
Discovery of triazine mimetics as potent antileishmanial agents. ACS Med Chem Lett (2013) 0.75
β-Nitrostyrenes as Potential Anti-leishmanial Agents. Front Microbiol (2016) 0.75
Salinomycin Hydroxamic Acids: Synthesis, Structure, and Biological Activity of Polyether Ionophore Hybrids. ACS Med Chem Lett (2016) 0.75
Complete heart block following a blow on the chest by a soccer ball: a rare manifestation of commotio cordis. Ann Noninvasive Electrocardiol (2012) 1.45
Characterization of natural antimony resistance in Leishmania donovani isolates. Am J Trop Med Hyg (2007) 1.29
Synthesis of chromenochalcones and evaluation of their in vitro antileishmanial activity. Bioorg Med Chem (2005) 1.27
Chemotherapy of leishmaniasis part II: synthesis and bioevaluation of substituted arylketene dithioacetals as antileishmanial agents. Eur J Med Chem (2005) 1.23
Medication error in anaesthesia and critical care: A cause for concern. Indian J Anaesth (2010) 1.17
Synthesis of 2,4,6-trisubstituted pyrimidines as antimalarial agents. Bioorg Med Chem (2005) 1.14
Use of Leishmania donovani field isolates expressing the luciferase reporter gene in in vitro drug screening. Antimicrob Agents Chemother (2005) 1.12
Incidental diagnosis of cor triatriatum in 2 elderly patients. J Am Coll Cardiol (2012) 1.08
Anatomical study of superficial fascia and localized fat deposits of abdomen. Indian J Plast Surg (2011) 1.07
Syntheses of novel antimycobacterial combinatorial libraries of structurally diverse substituted pyrimidines by three-component solid-phase reactions. Bioorg Med Chem Lett (2002) 1.06
Bis and tris indole alkaloids from marine organisms: new leads for drug discovery. Curr Med Chem (2007) 1.04
A small library of trisubstituted pyrimidines as antimalarial and antitubercular agents. Bioorg Med Chem Lett (2005) 1.03
Lipomatous meningioma: a study of five cases with brief review of literature. Neurol India (2011) 1.02
Variations in the course and microanatomical study of the lateral femoral cutaneous nerve and its clinical importance. Clin Anat (2010) 0.95
Pattern profiling of the herbal preparation picroliv using liquid chromatography-tandem mass spectrometry. J Chromatogr A (2004) 0.93
A convenient and biogenetic type synthesis of few naturally occurring chromeno dihydrochalcones and their in vitro antileishmanial activity. Bioorg Med Chem Lett (2004) 0.93
Long-term montelukast therapy in moderate to severe COPD--a preliminary observation. Respir Med (2004) 0.91
Dihydropyrido[2,3-d]pyrimidines as a new class of antileishmanial agents. Bioorg Med Chem (2005) 0.91
Pre-procedural Elevated White Blood Cell Count and Neutrophil-Lymphocyte (N/L) Ratio are Predictors of Ventricular Arrhythmias During Percutaneous Coronary Intervention. Cardiovasc Hematol Disord Drug Targets (2011) 0.89
Cascade intermolecular Michael addition-intramolecular azide/internal alkyne 1,3-dipolar cycloaddition reaction in one pot. Org Lett (2012) 0.88
Substituted quinolinyl chalcones and quinolinyl pyrimidines as a new class of anti-infective agents. Eur J Med Chem (2008) 0.88
Antimalarial activity and synthesis of new trisubstituted pyrimidines. Bioorg Med Chem Lett (2005) 0.87
Discovery of new 1,3,5-triazine scaffolds with potent activity against Mycobacterium tuberculosis H37Rv. Eur J Med Chem (2010) 0.87
Synthesis of new 4-aminoquinolines and quinoline-acridine hybrids as antimalarial agents. Bioorg Med Chem Lett (2010) 0.87
Synthesis of marine alkaloid: 8,9-dihydrocoscinamide B and its analogues as Novel class of antileishmanial agents. Bioorg Med Chem Lett (2007) 0.86
p-Type polymer-hybridized high-performance piezoelectric nanogenerators. Nano Lett (2012) 0.86
Synthesis of 4-pyrido-6-aryl-2-substituted amino pyrimidines as a new class of antimalarial agents. Bioorg Med Chem (2005) 0.86
Persistence of metaflumizone on cabbage (Brassica oleracea Linne) and soil, and its risk assessment. Environ Monit Assess (2012) 0.85
Synthesis of benzofuran scaffold-based potential PTP-1B inhibitors. Bioorg Med Chem (2006) 0.85
Dried blood spots: concepts, present status, and future perspectives in bioanalysis. Drug Test Anal (2014) 0.85
Paper-based piezoelectric nanogenerators with high thermal stability. Small (2011) 0.85
Synthesis and antileishmanial profile of some novel terpenyl pyrimidines. Eur J Med Chem (2004) 0.84
CpG oligodeoxynucleotide 2006 and miltefosine, a potential combination for treatment of experimental visceral leishmaniasis. Antimicrob Agents Chemother (2011) 0.84
Functional role of the MrpA- and MrpD-homologous protein subunits in enzyme complexes evolutionary related to respiratory chain complex I. Biochim Biophys Acta (2013) 0.84
Effect of concurrently coadministered drugs on the pharmacokinetic/pharmacodynamic profile of centchroman, a nonsteroidal oral contraceptive, in rats. Contraception (2006) 0.84
Antileishmanial efficacy of fluconazole and miltefosine in combination with an immunomodulator--picroliv. Parasitol Res (2011) 0.83
The role of human CYP2C8 and CYP2C9 variants in pioglitazone metabolism in vitro. Basic Clin Pharmacol Toxicol (2009) 0.83
Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines. Eur J Med Chem (2009) 0.83
Homologous protein subunits from Escherichia coli NADH:quinone oxidoreductase can functionally replace MrpA and MrpD in Bacillus subtilis. Biochim Biophys Acta (2011) 0.83
In Vitro and In Vivo pharmacokinetic studies of bulaquine (analogue of primaquine), a novel antirelapse antimalarial, in rat, rabbit and monkey--highlighting species similarities and differences. Biopharm Drug Dispos (2007) 0.83
CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis. J Antimicrob Chemother (2010) 0.83
Dihydrofolate reductase as a therapeutic target for infectious diseases: opportunities and challenges. Future Med Chem (2012) 0.83
Synthesis of 2-[3-(7-Chloro-quinolin-4-ylamino)-alkyl]-1-(substituted phenyl)-2,3,4,9-tetrahydro-1H-beta-carbolines as a new class of antimalarial agents. Bioorg Med Chem Lett (2008) 0.83
Antileishmanial agents part-IV: synthesis and antileishmanial activity of novel terpenyl pyrimidines. Eur J Med Chem (2005) 0.83
A natural product inspired hybrid approach towards the synthesis of novel pentamidine based scaffolds as potential anti-parasitic agents. Bioorg Med Chem Lett (2012) 0.82
Diversity oriented synthesis of pyran based polyfunctional stereogenic macrocyles and their conformational studies. Org Lett (2012) 0.82
Skeletal diverse synthesis of N-fused polycyclic heterocycles via the sequence of Ugi-type MCR and CuI-catalyzed coupling/tandem Pictet-Spengler reaction. J Org Chem (2012) 0.82
Immunomodulatory effect of picroliv on the efficacy of paromomycin and miltefosine in combination in experimental visceral leishmaniasis. Exp Parasitol (2010) 0.82
Persistence of azoxystrobin in/on grapes and soil in different grapes growing areas of India. Bull Environ Contam Toxicol (2010) 0.81
Synthesis of 2-[3,5-substituted pyrazol-1-yl]-4,6-trisubstituted triazine derivatives as antimalarial agents. Bioorg Med Chem Lett (2005) 0.81
Growth of high quality ZnO nanowires on graphene. J Nanosci Nanotechnol (2012) 0.81
Access to indole- and pyrrole-fused diketopiperazines via tandem Ugi-4CR/intramolecular cyclization and its regioselective ring-opening by intermolecular transamidation. J Org Chem (2012) 0.81
Ameliorative effect of Noni fruit extract on streptozotocin-induced memory impairment in mice. Behav Pharmacol (2013) 0.81
Synthesis of iodo-indoloazepinones in an iodine-mediated three-component domino reaction via a regioselective 7-endo-dig iodo-cyclization pathway. J Org Chem (2011) 0.81
Metabolism of CDRI-85/92, a new potent anti-ulcer agent, involving cis-trans conversion. Drug Metabol Drug Interact (2004) 0.81
Metabolism of 14C-azoxystrobin in water at different pH. J Environ Sci Health B (2010) 0.81
Synthesis and biological evaluation of new [1,2,4]triazino[5,6-b]indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6-b]indol-3-ylthio-pyrimidines against Leishmania donovani. Eur J Med Chem (2010) 0.81
Degradation of metaflumizone in soil: impact of varying moisture, light, temperature, atmospheric CO2 level, soil type and soil sterilization. Chemosphere (2012) 0.80
Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents. Bioorg Med Chem Lett (2009) 0.80
Antimalarial activity of 2,4,6-trisubstituted pyrimidines. Bioorg Med Chem Lett (2005) 0.80
Discovery of novel antileishmanial agents in an attempt to synthesize pentamidine-aplysinopsin hybrid molecule. J Med Chem (2009) 0.80
Synthesis and bioevaluation of novel 4-aminoquinoline-tetrazole derivatives as potent antimalarial agents. Eur J Med Chem (2013) 0.80
In vitro activities of new 2-substituted quinolines against Leishmania donovani. Antimicrob Agents Chemother (2011) 0.79
2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies. Eur J Med Chem (2011) 0.79
Mutation design and strain background influence the phenotype of Escherichia coli luxS mutants. Mol Microbiol (2013) 0.79
Synthesis and bioevaluation of hybrid 4-aminoquinoline triazines as a new class of antimalarial agents. Bioorg Med Chem Lett (2008) 0.79
A mechanism-based pharmacological evaluation of efficacy of Trigonella foenum graecum (fenugreek) seeds in regulation of dyslipidemia and oxidative stress in hyperlipidemic rats. J Cardiovasc Pharmacol (2013) 0.79
Comparisons between scolex and membrane antigens of Cysticercus fasciolaris and Cysticercus cellulosae larvae for immunodiagnosis of neurocysticercosis. J Microbiol Immunol Infect (2008) 0.79
Synthesis and molecular docking studies of 1-phenyl-4-glycosyl-dihydropyridines as potent antileishmanial agents. Eur J Med Chem (2010) 0.79
Enhancement in therapeutic efficacy of miltefosine in combination with synthetic bacterial lipopeptide, Pam3Cys against experimental Visceral Leishmaniasis. Exp Parasitol (2012) 0.79
Cyanuric chloride catalyzed mild protocol for synthesis of biologically active dihydro/spiro quinazolinones and quinazolinone-glycoconjugates. J Org Chem (2012) 0.79
Synthesis of substituted aryloxy alkyl and aryloxy aryl alkyl imidazoles as antileishmanial agents. Bioorg Med Chem Lett (2009) 0.79
Synthesis and optimization of antitubercular activities in a series of 4-(aryloxy)phenyl cyclopropyl methanols. Eur J Med Chem (2010) 0.79
Therapeutic switching in leishmania chemotherapy: a distinct approach towards unsatisfied treatment needs. J Parasit Dis (2011) 0.79
Functional screening of adrenergic receptors by measuring intracellular calcium using the FlexStation scanning fluorimeter. Biotechnol J (2009) 0.79
Piezoelectric two-dimensional nanosheets/anionic layer heterojunction for efficient direct current power generation. Sci Rep (2013) 0.79
Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents. Bioorg Med Chem Lett (2013) 0.78
Improved treatment of visceral leishmaniasis (kala-azar) by using combination of ketoconazole, miltefosine with an immunomodulator-Picroliv. Acta Trop (2011) 0.78
Synthesis and cytotoxicity evaluation of (tetrahydro-beta-carboline)-1,3,5-triazine hybrids as anticancer agents. Eur J Med Chem (2010) 0.78
Synthesis, structure-activity relationships, and biological studies of chromenochalcones as potential antileishmanial agents. J Med Chem (2014) 0.78
Expression of a PTS2-truncated hexokinase produces glucose toxicity in Leishmania donovani. Mol Biochem Parasitol (2009) 0.78